Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study
JMIR Public Health and Surveillance · 14.03.2023 · 9 · e43586
DOI: 10.2196/43586 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JMIR Public Health and Surveillance, online erschienen am 14.03.2023. Verfasst von Le Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Chin…. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Low-dose computed tomography (LDCT) screening is effective in reducing lung cancer mortality in smokers; however, the evidence in nonsmokers is scarce.
Objective
This study aimed to evaluate the participant rate and effectiveness of one-off LDCT screening for lung cancer among smokers and nonsmokers.
Methods
A population-based prospective cohort study was performed to enroll participants aged between 40 and 74 years from 2013 to 2019 from 4 cities in Zhejiang Province, China. Participants who were evaluated as having a high risk of lung cancer from an established risk score model were recommended to undergo LDCT screening. Follow-up outcomes were retrieved on June 30, 2020. The uptake rate of LDCT screening for evaluated high-risk participants and the detection rate of early-stage lung cancer (stage 0-I) were calculated. The lung cancer incidence, lung cancer mortality, and all-cause mortality were compared between the screened and nonscreened groups.
Results
At baseline, 62.56% (18,818/30,079) of smokers and 6% (5483/91,455) of nonsmokers were identified as high risk (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Prevention, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
- Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung and Esophagus), Hangzhou, China.
- Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
- Kecheng District People's Hospital of Quzhou, Quzhou, China.
ORCID-Profile: Le Wang, Youqing Wang, Fei Wang, Yumeng Gao, Zhimei Fang, Weiwei Gong, Huizhang Li, Chen Zhu, Yaoyao Chen, Lei Shi, Lingbin Du, Ni Li
Zitieren
APA
Wang, L., Wang, Y., Wang, F., Gao, Y., Fang, Z., Gong, W., Li, H., Zhu, C., Chen, Y., Shi, L., Du, L., & Li, N. (2023). Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study. JMIR Public Health and Surveillance, 9, e43586. https://doi.org/10.2196/43586
Vancouver
Wang L, Wang Y, Wang F, Gao Y, Fang Z, Gong W, et al. Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study. JMIR Public Health and Surveillance. 2023;9:e43586. doi:10.2196/43586
BibTeX
@article{Wang2023,
author = {Wang, Le and Wang, Youqing and Wang, Fei and Gao, Yumeng and Fang, Zhimei and Gong, Weiwei and Li, Huizhang and Zhu, Chen and Chen, Yaoyao and Shi, Lei and Du, Lingbin and Li, Ni},
title = {Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study},
journal = {JMIR Public Health and Surveillance},
year = {2023},
volume = {9},
pages = {e43586},
doi = {10.2196/43586}
}
EUVIMED